PLG - plasminogen Gene
Also Known as HAE4
Species: Homo sapiens
About PLG
This gene has 12 transcripts (splice variants), 238 orthologues, 14 paralogues and is associated with 4 phenotypes. Restricted expression toward liver (RPKM 588.1).
Summary
The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), Kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to Other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_000301.5 | NP_000292.1 | plasminogen isoform 1 precursor |
| NM_001168338.1 | NP_001161810.1 | plasminogen isoform 2 precursor |
| NM_000301.5 | NP_000292.1 | plasminogen isoform 1 precursor |
| NM_001168338.1 | NP_001161810.1 | plasminogen isoform 2 precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables apolipoprotein binding |
IPI
IPI: Inferred from physical interaction
|
16480936 | GOA |
| enables endopeptidase activity |
IDA
IDA: Inferred from direct assay
|
7679575 | GOA |
| enables enzyme binding |
IPI
IPI: Inferred from physical interaction
|
12666133 | GOA |
| enables kinase binding |
IPI
IPI: Inferred from physical interaction
|
24196407 | GOA |
| enables protease binding |
IPI
IPI: Inferred from physical interaction
|
7679575 | GOA |
| enables protein antigen binding |
IPI
IPI: Inferred from physical interaction
|
17849409 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
134998 | GOA |
| enables protein domain specific binding |
IPI
IPI: Inferred from physical interaction
|
9786936 | GOA |
| enables protein-folding chaperone binding |
IPI
IPI: Inferred from physical interaction
|
17307854 | GOA |
| enables serine-type endopeptidase activity |
IDA
IDA: Inferred from direct assay
|
14688145 | GOA |
| enables serine-type endopeptidase activity |
IMP
IMP: Inferred from mutant phenotype
|
18070902 | GOA |
| enables signaling receptor binding |
IPI
IPI: Inferred from physical interaction
|
20028034 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cell surface |
IDA
IDA: Inferred from direct assay
|
14699093 | GOA |
| located in external side of plasma membrane |
IDA
IDA: Inferred from direct assay
|
14699093 | GOA |
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
6216475 | GOA |
PLG Protein Structure
PAN_1: PAN domain (25 - 96)
Kringle: Kringle domain (103 - 181)
Kringle: Kringle domain (185 - 262)
Kringle: Kringle domain (275 - 352)
Kringle: Kringle domain (377 - 454)
Kringle: Kringle domain (481 - 560)
Trypsin: Trypsin (582 - 803)
- 0
- 200
- 400
- 600
- 810 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
plasminogen |
|
PLG Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Cross
|
PLG | P00747 | skc | Streptococcus equisimilis | P00779 | 12456874 | |
|
Intra
|
PLG | P00747 | APOH | Homo sapiens | P02749 | 16480936 | |
|
Cross
|
PLG | P00747 | q6v4l9_strpy | Streptococcus pyogenes | Q6V4L9 | 16319056 | |
|
Cross
|
PLG | P00747 | q6v4l1_strpy | Streptococcus pyogenes | Q6V4L1 | 16319056 | |
|
Cross
|
PLG | P00747 | q6v4l1_strpy | Streptococcus pyogenes | Q6V4L1 | 16319056 | |
|
Cross
|
PLG | P00747 | q6v4l4_strpy | Streptococcus pyogenes | Q6V4L4 | 16319056 | |
|
Cross
|
PLG | P00747 | q6v4l4_strpy | Streptococcus pyogenes | Q6V4L4 | 16319056 | |
|
Cross
|
PLG | P00747 | pdhC | Mycoplasma pneumoniae | P75392 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhC | Mycoplasma pneumoniae | P75392 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhD | Mycoplasma pneumoniae | P75393 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhD | Mycoplasma pneumoniae | P75393 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhB | Mycoplasma pneumoniae | P75391 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhB | Mycoplasma pneumoniae | P75391 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhB | Mycoplasma pneumoniae | P75391 | 23197176 | |
|
Cross
|
PLG | P00747 | pdhA | Mycoplasma pneumoniae | P75390 | 25978044 | |
|
Cross
|
PLG | P00747 | pdhA | Mycoplasma pneumoniae | P75390 | 25978044 | |
|
Cross
|
PLG | P00747 | sak | Staphylococcus aureus | Q99SU7 | 22321644 | |
|
Cross
|
PLG | P00747 | sak | Staphylococcus aureus | Q99SU7 | 22321644 |
Recombinant PLG Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P71939 | Plasminogen Protein, Human | P00747 (V98-P356) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Plasminogen Deficiency, Type I |
|
|
| Angioedema, Hereditary, 4 |
|
|
| Plg-Related Hereditary Angioedema With Normal C1inh |
|
|
| Hereditary Angioedema |
|
|
| Angioedema, Hereditary, 1 |
|
|
| Ligneous Conjunctivitis |
|
|
| Conjunctivitis |
|
|
| Thrombosis |
|
|
| Corneal Neovascularization |
|
|
| Angioedema |
|
|
| Intracranial Embolism |
|
|
| Hepatic Veno-Occlusive Disease |
|
|
| Brain Stem Infarction |
|
|
| Basilar Artery Occlusion |
|
|
| Alveolar Periostitis |
|
|
| Hemangioendothelioma |
|
|
| Occlusion Precerebral Artery |
|
|
| Basilar Artery Insufficiency |
|
|
| Cystic Fibrosis |
|
|
| Central Retinal Artery Occlusion |
|
|
| Cerebral Artery Occlusion |
|
|
| Pneumonic Plague |
|
|
| Pulmonary Artery Disease |
|
|
| Middle Cerebral Artery Infarction |
|
|
| Post-Thrombotic Syndrome |
|
|
| Carotid Artery Occlusion |
|
|
| Covid-19 |
|
|
| Septicemic Plague |
|
|
| Vertebral Artery Occlusion |
|
|
| Retinal Vascular Disease |
|
|
| Disseminated Intravascular Coagulation |
|
|
| Livedoid Vasculitis |
|
|
| Speech And Communication Disorders |
|
|
| Thrombophilia Due To Activated Protein C Resistance |
|
|
| Inferior Myocardial Infarction |
|
|
| Posterior Cerebral Artery Infarction |
|
|
| Alpha-2-Plasmin Inhibitor Deficiency |
|
|
| Anterior Cerebral Artery Infarction |
|
|
| Retinal Vascular Occlusion |
|
|
| Basal Ganglia Cerebrovascular Disease |
|
|
| Hemolytic-Uremic Syndrome |
|
|
| Lateral Medullary Syndrome |
|
|
| Pseudomembranous Conjunctivitis |
|
|
| Brown-Sequard Syndrome |
|
|
| Thoracic Outlet Syndrome |
|
|
| Gynatresia |
|
|
| Vitreous Detachment |
|
|
| Bubonic Plague |
|
|
| Granulomatosis With Polyangiitis |
|
|
| Conversion Disorder |
|
|
| Vein Disease |
|
|
| Osteonecrosis |
|
|
| Hemopericardium |
|
|
| Leech Infestation |
|
|
| Branch Retinal Artery Occlusion |
|
|
| Vertebrobasilar Insufficiency |
|
|
| Vascular Cancer |
|
|
| Central Retinal Vein Occlusion |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Secondary Hyperparathyroidism Of Renal Origin |
|
|
| Intracranial Thrombosis |
|
|
| Carotid Artery Disease |
|
|
| Sagittal Sinus Thrombosis |
|
|
| Acute Anterolateral Myocardial Infarction |
|
|
| Nonbacterial Thrombotic Endocarditis |
|
|
| Acute Cor Pulmonale |
|
|
| Encephalopathy, Familial, With Neuroserpin Inclusion Bodies |
|
|
| Ischemia |
|
|
| Adult Respiratory Distress Syndrome |
|
|
| Pleural Empyema |
|
|
| Antithrombin Iii Deficiency |
|
|
| Heparin Cofactor Ii Deficiency |
|
|
| Intracranial Sinus Thrombosis |
|
|
| Aspergillosis |
|
|
| Acute Pulmonary Heart Disease |
|
|
| Chronic Venous Insufficiency |
|
|
| Rubeosis Iridis |
|
|
| Anteroseptal Myocardial Infarction |
|
|
| Microvascular Complications Of Diabetes 5 |
|
|
| Stroke, Ischemic |
|
|
| Cholesterol Embolism |
|
|
| Coronary Thrombosis |
|
|
| Cerebral Arterial Disease |
|
|
| Locked-In Syndrome |
|
|
| Purpura Fulminans |
|
|
| Quebec Platelet Disorder |
|
|
| Plague |
|
|
| Hydronephrosis |
|
|
| Compartment Syndrome |
|
|
| Transient Cerebral Ischemia |
|
|
| Otitis Media |
|
|
| Pulmonary Artery Leiomyosarcoma |
|
|
| Retinal Artery Occlusion |
|
|
| Necrotizing Fasciitis |
|
|
| Carotid Artery Dissection |
|
|
| Anterior Spinal Artery Syndrome |
|
|
| Blood Coagulation Disease |
|
|
| Dysbaric Osteonecrosis |
|
|
| Pancreatic Cancer |
|
|
| Thrombophlebitis |
|
|
| Portal Vein Thrombosis |
|
|
| Endocardium Disease |
|
|
| Neovascular Glaucoma |
|
|
| Infective Endocarditis |
|
|
| Carotid Artery Thrombosis |
|
|
| Lemierre'S Syndrome |
|
|
| Erysipeloid |
|
|
| Moyamoya Disease 1 |
|
|
| Medulloadrenal Hyperfunction |
|
|
| Vitreous Disease |
|
|
| Acute Poststreptococcal Glomerulonephritis |
|
|
| Melanoma, Uveal |
|
|
| Kuhnt-Junius Degeneration |
|
|
| Cerebrovascular Disease |
|
|
| Hepatic Vascular Disease |
|
|
| Aphasia |
|
|
| Hemiplegia |
|
|
| Blood Group, Globoside System |
|
|
| Limb Ischemia |
|
|
| Afibrinogenemia, Congenital |
|
|
| Bladder Cancer |
|
|
| Anosognosia |
|
|
| Cardiac Tamponade |
|
|
| Ovarian Cancer |
|
|
| Patent Foramen Ovale |
|
|
| Macular Holes |
|
|
| Nephrotic Syndrome |
|
|
| Peripheral Vascular Disease |
|
|
| Facial Paralysis |
|
|
| Intracranial Berry Aneurysm |
|
|
| Facial Nerve Disease |
|
|
| Heart Conduction Disease |
|
|
| Retinal Perforation |
|
|
| Myocardial Infarction |
|
|
| Hypertension, Essential |
|
|
| Macular Degeneration, Age-Related, 1 |
|
|
| Mitral Valve Stenosis |
|
|
| Obstructive Hydrocephalus |
|
|
| Endophthalmitis |
|
|
| Malaria |
|
|
| Central Nervous System Origin Vertigo |
|
|
| Cardiovascular System Disease |
|
|
| Conjunctival Disease |
|
|
| Intracranial Hypertension |
|
|
| Autoimmune Disease Of Cardiovascular System |
|
|
| Endometrial Cancer |
|
|
| Arteriovenous Malformation |
|
|
| Premature Ovarian Failure 19 |
|
|
| Budd-Chiari Syndrome |
|
|
| Aortic Dissection |
|
|
| Barre-Lieou Syndrome |
|
|
| Atrial Heart Septal Defect |
|
|
| Colorectal Cancer |
|
|
| Arteries, Anomalies Of |
|
|
| Melanoma |
|
|
| Acquired Color Blindness |
|
|
| Brain Cancer |
|
|
| Systemic Lupus Erythematosus |
|
|
| Blood Platelet Disease |
|
|
| Hepatocellular Carcinoma |
|
|
| Aortic Aneurysm, Familial Abdominal, 1 |
|
|
| Arteriovenous Malformations Of The Brain |
|
|
| Deficiency Anemia |
|
|
| Respiratory Failure |
|
|
| Hemolytic Uremic Syndrome, Atypical 1 |
|
|
| Nervous System Disease |
|
|
| Migraine With Or Without Aura 1 |
|
|
| Eye Disease |
|
|
| Aortic Aneurysm, Familial Thoracic 1 |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Type 2 Diabetes Mellitus |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | PLG | VGNC | VGNC:110549 |
| Felis catus | PLG | VGNC | VGNC:102484 |
| Rattus norvegicus | PLG | RGD | RGD:619893 |
| Mus musculus | PLG | MGD | MGI:97620 |
| Macaca mulatta | PLG | VGNC | VGNC:82206 |
| Others | PLG | NCBI |